Company News in the Life Science Industry

»

Reset 

Mitsubishi Tanabe Pharma Canada Announces That Company's Treatment for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plan in Alberta

TORONTO, June 1, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), today announced that RADICAVA(®) (edaravone) is now listed on the Alberta Drug Benefit List formulary (special authorization). RADICAVA is an intravenous... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
Related companies:  Mitsubishi Tanabe Pharma Canada, Inc.

Nextleaf Solutions Receives Patents for Cannabis Oil Extraction in North America, Europe, and Asia

VANCOUVER, June 1, 2020 /CNW/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF), Canada's most innovative cannabis extractor, announced today that it has been issued more patents in North America, Asia, and... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

WELL Health Completes its Seventh EMR Acquisition with the Closing of Indivica Acquisition

VANCOUVER, June 1, 2020 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (the "Company" or "WELL"), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is pleased to announce that is has closed the previously... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
Related companies:  WELL Health Technologies Corp.

Hi. Saskatchewan, we're back!

SASKATCHEWAN, SK, June 1, 2020 /CNW/ - As of today, Tweed cannabis stores across Saskatchewan are reopening to foot traffic guests who are looking to purchase their cannabis products in store, following a period of reduced operations in response to the COVID-19 pandemic.

Read more ››
By: PR Newswire Association LLC. - 01 Jun 2020

ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting

Read more ››
By: GlobenewsWire - 01 Jun 2020

Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA

Read more ››
By: GlobenewsWire - 01 Jun 2020
Related companies:  Hutchison China MediTech Limited (Chi-Med)

Admedus Changes Name to Anteris Technologies Ltd

Read more ››
By: GlobenewsWire - 01 Jun 2020

Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares

Read more ››
By: GlobenewsWire - 01 Jun 2020
Related companies:  Adaptimmune Therapeutics plc.

Remestemcel-L Improves Respiratory and Functional Outcomes in Patients With Inflammatory Lung Disease

Read more ››
By: GlobenewsWire - 01 Jun 2020
Related companies:  Mesoblast Limited

RadNet, Inc. to Present at the Jefferies 2020 Virtual Healthcare Conference on June 2, 2020

Read more ››
By: GlobenewsWire - 01 Jun 2020
Related companies:  RadNet, Inc

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal

SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors

NORTH CHICAGO, Ill. and BEIJING, June 1, 2020 /PRNewswire/ -- AbbVie (NYSE:ABBV), a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company, today announced a global, strategic collaboration to develop and commercialize SHP2 inhibitors,... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
Related companies:  AbbVie Inc.

Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)

SHANGHAI, June 1, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord) jointly announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
Related companies:  Henlius

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Publication in Nature Communications Highlights the Preclinical Development of SYNB1891 and its Potential as a Dual Innate Immune Activator to Stimulate an Immune Response in Difficult to Treat Tumors

CAMBRIDGE, Mass., June 1, 2020 /PRNewswire/ -- Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced the publication in Nature Communications of preclinical data supporting its first... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
Related companies:  Synlogic, Inc.

Zentiva Expands Production Capacity by Completing Acquisition of Ankleshwar Manufacturing Site

PRAGUE, June 1, 2020 /PRNewswire/ -- Zentiva Group announces the completion of its acquisition of a manufacturing site in Ankleshwar, India, from Sanofi. The finalization of the deal increases the number of wholly-owned Zentiva production sites worldwide and will enable Zentiva to serve more... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

New Analysis Confirms That Multiple Myeloma Patients in the OCEAN Study Stay on Treatment Longer Than Previously Estimated - Results Expected H1-2021

STOCKHOLM, June 1, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces that patients in the OCEAN study stay on treatment longer than previously estimated. As a consequence, top-line results are estimated for H1 2021 instead of previously communicated Q4 2020. Patient... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
Related companies:  Oncopeptides AB

RDIF and ChemRar to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia, Avifavir, to the Country's Hospitals in June

MOSCOW, June 1, 2020 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and the ChemRar Group will deliver 60,000 courses of Avifavir to Russian hospitals in June. Avifavir is Russia's first COVID-19 drug and has shown high efficacy in... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

IrisGuard Leads the Way in Contact-free Iris Verification Payment Services with ISO Level 1 PAD Test Compliance

MILTON KEYNES, England, June 1, 2020 /PRNewswire/ -- IrisGuard are delighted to announce that they have received their final certification and notice of compliance for Presentation Attack Detection to internationally recognised ISO 30107-3 standards from independent test house specialists, iBeta... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Reporter Gene Assay Market Size Worth $9.0 Billion by 2027: Grand View Research, Inc.

SAN FRANCISCO, June 1, 2020 /PRNewswire/ --The global... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Explore our database of over 50,000 companies